Avidity Partners Management LP Harpoon Therapeutics, Inc. Transaction History

Avidity Partners Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.69 - $7.83 $6.77 Million - $9.32 Million	-1,190,600 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$7.88 - $14.0 $2.44 Million - $4.33 Million	-309,400 Reduced 20.63%	1,190,600 $9.41 Million
Q2 2021 Aug 16, 2021	BUY	$13.81 - $23.25 $1.27 Million - $2.14 Million	92,000 Added 6.53%	1,500,000 $20.8 Million
Q1 2021 May 17, 2021	BUY	$17.65 - $24.16 $11 Million - $15.1 Million	623,000 Added 79.36%	1,408,000 $29.5 Million
Q4 2020 Feb 16, 2021	SELL	$12.83 - $17.84 $4.96 Million - $6.9 Million	-386,700 Reduced 33.0%	785,000 $13 Million
Q3 2020 Nov 16, 2020	SELL	$11.01 - $18.52 $381,507 - $641,736	-34,651 Reduced 2.87%	1,171,700 $19.9 Million
Q2 2020 Aug 14, 2020	BUY	$11.11 - $24.72 $13.4 Million - $29.8 Million	1,206,351 New	1,206,351 $20 Million

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.